Cytokine modulation of the innate immune response in feline immunodeficiency virus - Infected cats

被引:9
作者
Dean, GA [1 ]
Lavoy, A [1 ]
Yearley, J [1 ]
Stanton, C [1 ]
机构
[1] N Carolina State Univ, Coll Vet Med, Dept Mol BIomed Sci, Raleigh, NC 27606 USA
关键词
D O I
10.1086/503873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. In vitro data suggest that innate immune function in human immunodeficiency virus type 1 infected patients is compromised; however, in vivo studies are lacking. Feline immunodeficiency virus (FIV) infection in cats provides an excellent model to explore innate immune function in vivo. The innate response against Listeria monocytogenes is well understood, making it a useful immune probe. Methods. Recombinant L. monocytogenes carrying eukaryotic expression plasmids for feline tumor necrosis factor (TNF)-alpha, interleukin (IL)-10, interferon (IFN)-gamma, and IL-15 were created to determine whether specific cytokines would modulate innate immune function. L. monocytogenes was delivered subcutaneously, and local lymph nodes were evaluated for size, cell subpopulations, and L. monocytogenes burden. Two months later, memory responses were evaluated by IFN-gamma enzyme-linked immunospot assay. Results. FIV-positive cats had significantly less lymph-node enlargement and a greater L. monocytogenes burden than FIV-negative control cats. TNF-alpha improved listericidal activity in FIV-negative control cats but not in FIV-positive cats, whereas IL-10 modestly reduced function in FIV-negative control cats. IFN-gamma improved memory responses but not clearance of L. monocytogenes. IL-15 improved innate function in FIV-positive cats and increased the percentage of natural killer cells. Conclusions. Lentivirus infection impairs innate immune function in vivo, and IL-15 can significantly restore function. We hypothesize that altered dendritic-cell function and increased regulatory T cell activity may underlie the innate immune defect in HIV infection.
引用
收藏
页码:1520 / 1527
页数:8
相关论文
共 50 条
[1]   Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients [J].
Ahmad, A ;
Ahmad, R ;
Toma, E ;
Morisset, R ;
Menezes, J .
AIDS, 2000, 14 (06) :744-746
[2]   Studies on the production of IL-15 in HIV-infected/AIDS patients [J].
Ahmad, R ;
Sindhu, STA ;
Toma, E ;
Morisset, R ;
Ahmad, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (02) :81-90
[3]  
Andersson Å, 1998, J IMMUNOL, V161, P5600
[4]   Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes [J].
Auerbuch, V ;
Brockstedt, DG ;
Meyer-Morse, N ;
O'Riordan, M ;
Portnoy, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :527-533
[5]   THE ROLE OF NATURAL-KILLER-CELLS IN INNATE RESISTANCE TO INFECTION [J].
BANCROFT, GJ .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (04) :503-510
[6]   Relative contributions of NK and CD8 T cells to IFN-γ mediated innate immune protection against Listeria monocytogenes [J].
Berg, RE ;
Crossley, E ;
Murray, S ;
Forman, J .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1751-1757
[7]   MODULATION OF THE ANTILISTERIAL ACTIVITY OF HUMAN BLOOD-DERIVED MACROPHAGES BY ACTIVATING AND DEACTIVATING CYTOKINES [J].
BLAUER, F ;
GROSCURTH, P ;
SCHNEEMANN, M ;
SCHOEDON, G ;
SCHAFFNER, A .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (02) :105-114
[8]   REQUIREMENT OF ENDOGENOUS INTERFERON-GAMMA PRODUCTION FOR RESOLUTION OF LISTERIA-MONOCYTOGENES INFECTION [J].
BUCHMEIER, NA ;
SCHREIBER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7404-7408
[9]   Transmission and immunopathogenesis of FIV in cats as a model for HIV [J].
Burkhard, MJ ;
Dean, GA .
CURRENT HIV RESEARCH, 2003, 1 (01) :15-29
[10]   Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy [J].
D'Ettorre, G ;
Forcina, G ;
Andreotti, M ;
Sarmati, L ;
Palmisano, L ;
Andreoni, M ;
Vella, S ;
Mastroianni, CM ;
Vullo, V .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (02) :280-285